On this page
Activity aim
In this clinical audit, you will review the management of five patients with established atherosclerotic cardiovascular disease (ASCVD) who are overweight or obese, with reference to Australian and international best practice guidelines, and evaluate how you can further reduce their residual risk of an ASCVD event.
Why take part in this program?
- Identify five patients with established ASCVD who are overweight or obese, and optimise their management in line with latest Australian and international best practice guidelines
- Earn 6.5 CPD hours upon completion.
Inclusion criteria
Patients who are eligible for this clinical audit are adults who are:
- Overweight or obesity (BMI ≥ 27 kg/m2)
- Age ≥ 45 years and established ASCVD*
- No prior history of diabetes (HbA1c < 6.5%)
*Myocardial infarction ≥ 60 days ago, stroke ≥ 60 days ago, or symptomatic PAD; NYHA class IV excluded
How long should it take?
The program has been designed to take approximately 4-6 weeks to complete. This includes patient recall from your practice, patient consult and program evaluation.
Tips to recruit patients
Recruitment may occur:
- Opportunistically as you consult appropriate patients as part of usual care.
- By active recall.
Learning outcomes
On completion of this educational activity participants will be able to:
Review lifestyle behaviour adherence in patients with ASCVD and overweight or obesity and offer solutions to promote heathy lifestyle change
Identify ASCVD patients who are not meeting LDL-C targets and/or blood pressure targets, and use evidence-based strategies to adjust their lipid and blood pressure lowering therapies for optimal cardiovascular risk management
Consider whether patients require initiation of antiplatelet or anticoagulant therapy per current Australian and international recommendations
Select weight loss medications to reduce the risk of major adverse cardiovascular events (MACE) as part of the secondary prevention of ASCVD in overweight or obesity.
New clinical audit
Boost your Measuring Outcomes CPD hours with this new clinical audit
Residual risk in CVD: Same war, new battle - Predisposing activity
Residual risk in CVD: Same war, new battle - Education
Residual risk in CVD: Same war, new battle - Audit introduction
Residual risk in CVD: Same war, new battle - Patient entry
Residual risk in CVD: Same war, new battle - Reflective activity
Residual risk in CVD: Same war, new battle - Reinforcing activity
Residual risk in CVD: Same war, new battle - Evaluation
Sponsored by
